Alicia Butterfield claims Anthem denied her Zepbound once the drug got her below morbid obesity. A Los Angeles judge stayed her case pending arbitration.
Recap by typeshit. Full story at MyNewsLA.com.
STAT
Members of Congress from both parties want the FDA to stop imports of copycat versions of Eli Lilly's experimental obesity drug, which is still in trials.
Bloomberg says the boom in GLP-1 use has opened a risky trade in weight loss drugs brought into Brazil illegally.
The pharmacy boards group, per InsideHealthPolicy, ties reported deaths linked to retatrutide to weak enforcement against gray-market peptide sellers.
Judge Raphael Leite Guedes in Maranhão found tirzepatide counts as a home-use drug under Law 9,656/98, even when a clinic gives the shots.
A general explainer on how GLP-1 receptor agonists affect blood sugar and appetite, with advice on support while taking them.
Among 208,970 matched adults with type 2 diabetes, GLP-1 starters had 0.15% new diagnoses versus 0.10% on DPP-4 drugs. Authors call it a signal needing confirmation.
Loading…